Key stats
About Direxion Daily Healthcare Bull 3X Shares
Home page
Inception date
Jun 15, 2011
Structure
Open-Ended Fund
Replication method
Synthetic
Distributes
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Tax on distributions
Ordinary income
Primary advisor
Rafferty Asset Management LLC
Distributor
Foreside Fund Services LLC
As a levered product, CURE is not a buy-and-hold ETF, it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare nameslike J&J, Pfizer, and Merckin the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. As a short-term product, CURE's expense ratio is less important than all in trading costs. Trading can be volatile. Check the latest Tradability data on this page.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Cash
Stocks86.41%
Health Technology68.78%
Health Services13.02%
Distribution Services2.64%
Retail Trade1.32%
Commercial Services0.65%
Bonds, Cash & Other13.59%
Cash13.59%
Stock breakdown by region
North America97.43%
Europe2.57%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history